BDBM114716 US20260001887, Compound D SPV Therapeutics, WO2020/140052

SMILES CN(C)C(=O)c1cc2cnc(NC3CCN(S(C)(=O)=O)CC3)nc2n1C12CC(C1)C2

InChI Key InChIKey=QIJADTSTMGBTNX-UHFFFAOYSA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 114716   

TargetCyclin-dependent kinase 4(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 114716BDBM114716(US20260001887, Compound D SPV Therapeutics, WO2020...)
Affinity DataIC50: 16nMAssay Description:Keywords: Heat Shock Factor-1 (HSF-1), Stress Response, MG132, NIH3T3, Luminescence Assay Overview: Confirmation testing of small molecules identifie...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/13/2026
Entry Details
US Patent

TargetCyclin-dependent kinase 1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 114716BDBM114716(US20260001887, Compound D SPV Therapeutics, WO2020...)
Affinity DataIC50: 230nMAssay Description:Keywords: Heat Shock Factor-1 (HSF-1), Stress Response, MG132, NIH3T3, Luminescence Assay Overview: Confirmation testing of small molecules identifie...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/13/2026
Entry Details
US Patent